undamentalytics Newsletter

Hsiao Jane Ph D: insider trades

Officer, Director at 2 companies we cover. 24 open-market purchases and no sales not made under a pre-set plan, reported from January 25, 2011 to January 17, 2024.

Would copying Hsiao Jane Ph D’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 12 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on April 5, 2013 into $12,028 by November 2, 2026, +1.4% a year. The copy held shares only 34% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $25,185, +7.0% a year (the S&P 500 held throughout made $61,273, +14.3% a year). Beta against the index was 0.23. Twelve months after each report, the average purchase was −15.8% against the S&P 500 (median −38.1%), and 33% beat it. Measured from the trade date, the insider’s own timing, the average was −17.6%.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k$60.0k 2013201520172019202120232025 $61.3k$25.2k$12.0k
Copying Hsiao Jane Ph DS&P 500, same days investedS&P 500, held throughout $10,000 copying Hsiao Jane Ph D’s open-market purchases from April 5, 2013, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+1.4%
S&P 500, same days invested
+7.0% (held throughout +14.3%)
Time in shares
34%
Sharpe ratio (S&P 500)
0.11 (0.77)
Biggest drop (S&P 500)
−73% (−34%)
Market sensitivity (beta)
0.23
Purchases copied
12

Trade by trade

Hsiao Jane Ph D: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 12 −10.4% −12.5% 8% 5 −2.86 0.046 Some evidence: behind
Purchases, 6 months after the report 12 −7.9% −9.7% 33% 5 −0.55 0.61 No reliable evidence
Purchases, 12 months after the report 12 −15.8% −38.1% 33% 5 −0.75 0.50 No reliable evidence
Purchases, 12 months after the trade 12 −17.6% −39.5% 33% 5 −0.82 0.46 No reliable evidence
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Opko Health, Inc. OPK Vice Chairman & CTO220January 25, 2011January 17, 2024
Cocrystal Pharma, Inc. COCP —20March 27, 2015March 17, 2016

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
January 17, 2024January 17, 2024 OPK Purchase $142,500 not yetnot yetnot yet
January 8, 2024January 5, 2024 OPK Purchase $130,509 not yetnot yetnot yet
November 13, 2023November 10, 2023 OPK Purchase $126,659 not yetnot yetnot yet
October 25, 2019October 25, 2019 OPK Purchase $600,000 not yetnot yetnot yet
May 10, 2019May 9, 2019 OPK Purchase $20,333 not yetnot yetnot yet
February 5, 2019July 27, 2012 OPK Purchase $296,100 not yetnot yetnot yet
May 12, 2017May 11, 2017 OPK Purchase $138,500 −12.5%−45.6%−52.2%
May 11, 2017May 10, 2017 OPK Purchase $278,705 −15.9%−49.9%−53.4%
March 18, 2016March 17, 2016 OPK Purchase $12,785 −20.1%−46.4%−45.0%
March 17, 2016March 16, 2016 OPK Purchase $11,988 −19.6%−45.8%−38.1%
March 17, 2016March 15, 2016 COCP Purchase $630,000 not yetnot yetnot yet
March 16, 2016March 14, 2016 OPK Purchase $24,144 −17.9%−45.0%−40.9%
March 15, 2016March 11, 2016 OPK Purchase $12,252 −12.5%−38.1%−42.2%
March 15, 2016March 8, 2016 OPK Purchase $35,787 −12.5%−38.1%−42.3%
August 26, 2015August 25, 2015 OPK Purchase $216,360 −5.9%−29.4%−32.5%
March 27, 2015March 25, 2015 COCP Purchase $2,024,000 not yetnot yetnot yet
April 15, 2014April 15, 2014 OPK Purchase $80,300 −2.4%+57.5%+62.7%
January 31, 2014January 30, 2014 OPK Purchase $81,380 +0.9%+41.5%+35.4%
January 30, 2014January 28, 2014 OPK Purchase $81,998 −1.8%+43.7%+24.9%
April 4, 2013April 3, 2013 OPK Purchase $34,950 −4.5%+5.6%+13.0%
October 10, 2012October 9, 2012 OPK Purchase $43,366 not yetnot yetnot yet
March 30, 2012March 29, 2012 OPK Purchase $46,952 not yetnot yetnot yet
October 5, 2011October 5, 2011 OPK Purchase $4,320,000 not yetnot yetnot yet
January 25, 2011January 21, 2011 OPK Purchase $710,000 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Hsiao Jane Ph D traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.